Clinical Trial Detail

NCT ID NCT02580058
Title A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications

peritoneum cancer

fallopian tube cancer

ovarian cancer

Therapies

Doxorubicin

Avelumab

Age Groups: adult

No variant requirements are available.